BioFlyte

Albuquerque, United States

BioFlyte is a biodefense company that commercializes a new class of fieldable biological threat collection.

$5.4M raised

Aug 2023

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BioFlyte raised?

BioFlyte has raised $5.4M in total funding. The most recent round was Series B. The last funding was announced in August 2023.

Who are BioFlyte's investors?

BioFlyte's investors include Scout Ventures, Cottonwood Technology Fund, Anzu Partners, New Mexico Vintage Fund.

Where is BioFlyte headquartered?

BioFlyte is headquartered in Albuquerque, United States.

What does BioFlyte do?

BioFlyte is a biodefense company that commercializes a new class of fieldable biological threat collection.

What stage is BioFlyte at?

BioFlyte is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2023.

MLA

"BioFlyte — Funding & Investors." VCBacked, August 10, 2023, https://www.vcbacked.co/company/bioflyte. Accessed July 2, 2026.

APA

VCBacked. (2023). BioFlyte — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bioflyte

Wikipedia (cite web)

{{cite web |title=BioFlyte — Funding & Investors |url=https://www.vcbacked.co/company/bioflyte |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2023.